Ascending thoracic aorta stent graft GORE® TAG®

ePTFE

Building on 25 years of TEVAR experience we’ve combined a proven stent graft with controlled, staged deployment, uniquely designed for trusted conformability and anatomical adaptability. “Gore has a long history with TEVAR. We look back on 25 years and think of all the milestones. There's been an enduring benefit to patients over a long period of time.” - Michael D. Dake, M.D.* “They were the first ones to come out with a TEVAR device, and a branch arch device, and a dissection indication. They have a whole series of firsts for us and our patients.” - Joseph E. Bavaria, M.D.* From the first FDA approved thoracic device to future development, we are TEVAR. “Gore really helped pioneer these devices and advance the technology and make it applicable to everyday treatment of these patients.” - Darren B. Schneider, M.D.* “The first time I used the [GORE® TAG® Thoracic Endoprosthesis ] I was a resident. Fast forward 20 years, what we are doing now, we couldn't even think about it.” - Gustavo Oderich, M.D.* INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Conformable Thoracic Stent Graft is intended for endovascular repair of all lesions of the descending thoracic aorta, including: isolated lesions in patients who have appropriate anatomy, including: adequate iliac/femoral access, aortic inner diameter in the range of 16-42 mm, ≥ 20 mm non-aneurysmal aorta proximal and distal to the lesion;